These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12209049)

  • 1. Robin goodfellow.
    Rheumatology (Oxford); 2002 Sep; 41(9):1081. PubMed ID: 12209049
    [No Abstract]   [Full Text] [Related]  

  • 2. Robin Goodfellow.
    Rheumatology (Oxford); 2001 Nov; 40(11):1322. PubMed ID: 11709624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rheumatology: present and future].
    Braun J
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1735. PubMed ID: 22933193
    [No Abstract]   [Full Text] [Related]  

  • 4. [New trends in rheumatology. The Danish Society of Rheumatology].
    Andersen LS; Gam AN; Hansen A; Kollerup G; Rasmussen C; Rasmussen JM; Schiøttz-Christensen B; Slot O; Thamsborg G
    Ugeskr Laeger; 2003 Mar; 165(12):1255. PubMed ID: 12701305
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current status of methotrexate].
    Fiehn C
    Z Rheumatol; 2011 Feb; 70(2):99-100. PubMed ID: 21312022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuous quick development of rheumatology].
    Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M
    Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087
    [No Abstract]   [Full Text] [Related]  

  • 7. Are individual patient trials (n-of-1 trials) in rheumatology worth the extra effort?
    Peloso PM
    J Rheumatol; 2004 Jan; 31(1):8-11. PubMed ID: 14705210
    [No Abstract]   [Full Text] [Related]  

  • 8. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
    Silman A; Rudkin S; Walley T
    Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in targeted therapies XII. Preface.
    Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
    [No Abstract]   [Full Text] [Related]  

  • 10. The history of the use of sulphasalazine in rheumatology.
    Amos RS
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robin Goodfellow.
    Rheumatology (Oxford); 2002 Feb; 41(2):238. PubMed ID: 11886983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic strategies: Ways to remission].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
    [No Abstract]   [Full Text] [Related]  

  • 13. Robin goodfellow.
    Rheumatology (Oxford); 2002 May; 41(5):598. PubMed ID: 12011394
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biosimilars].
    Burmester GR; Müller-Ladner U
    Z Rheumatol; 2015 Oct; 74(8):670-1. PubMed ID: 26450433
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.
    Yelin E; Katz P
    Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
    Woodworth TG; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day R; Lipani J; Brooks P
    J Rheumatol; 2001 May; 28(5):1163-9. PubMed ID: 11361207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence based medicine in rheumatology].
    Gause A; Raspe HH
    Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
    Weisman MH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
    [No Abstract]   [Full Text] [Related]  

  • 20. [The future of RA treatment].
    Matsubara T
    Ryumachi; 1997 Oct; 37(5):679-80. PubMed ID: 9396369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.